Issue 6, 2022
From the journal:

Biomaterials Science

Correction: Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization

Qiqi Zhang,a   Jianhua He,a   Fengfei Xu,a   Xinya Huang,a   Yanyan Wang,a   Wenli Zhang*a  and  Jianping Liu*a  

* Corresponding authors

a Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu 210009, P. R. China
E-mail: zwllz@163.com, jianpingliu1293@163.com

Abstract

Correction for ‘Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization’ by Qiqi Zhang et al., Biomater. Sci., 2021, 9, 6153–6168, DOI: 10.1039/D1BM00610J.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D2BM90014A
Article type
Correction
Submitted
15 Feb 2022
Accepted
15 Feb 2022
First published
23 Feb 2022
This article is Open Access
Creative Commons BY license

Biomater. Sci., 2022,10, 1594-1595

Permissions

Request permissions

Correction: Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization

Q. Zhang, J. He, F. Xu, X. Huang, Y. Wang, W. Zhang and J. Liu, Biomater. Sci., 2022, 10, 1594 DOI: 10.1039/D2BM90014A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements